Omalizumab in Allergic bronchopulmonary aspergillosis is associated with fewer episodes of exacerbation and reduction of steroids dose.
Allergic bronchopulmonary aspergillosis and omalizumab
Version of Record online: 26 APR 2011
© 2011 John Wiley & Sons A/S
Volume 66, Issue 9, pages 1254–1256, September 2011
How to Cite
Tillie-Leblond, I., Germaud, P., Leroyer, C., Tétu, L., Girard, F., Devouassoux, G., Grignet, J.-P., Prudhomme, A., Dusser, D. and Wallaert, B. (2011), Allergic bronchopulmonary aspergillosis and omalizumab. Allergy, 66: 1254–1256. doi: 10.1111/j.1398-9995.2011.02599.x
- Issue online: 1 AUG 2011
- Version of Record online: 26 APR 2011
- Accepted for publication 24 March 2011
- 6Effects of omalizumab in Aspergillus-associated airway disease. Thorax 2011;11:epub., , , , , et al.